XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
   Pharmacotherapy
   Radiotherapy
   Vaccination
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 29th, 2006 - 03:49:53

Vaccination Channel
subscribe to Vaccination newsletter

Latest Research : Cancer : Therapy : Vaccination

   DISCUSS   |   EMAIL   |   PRINT
First ever shots of the cervical cancer vaccine administered in Queensland
Aug 29, 2006, 03:41, Reviewed by: Dr. Priya Saxena

"We're really happy that the vaccine has come through with 100 percent on the test trials but also really sad because my father can't be here with us today."

 

The vaccine prevents four of dozens of strains of the human papillomavirus (HPV) which cause genital warts and cervical cancer.
UQ Professor Ian Frazer administered the first shots of the cervical cancer vaccine Gardasil in Queensland this afternoon at the Princess Alexandra Hospital.

Rochedale sisters Emma and Rachel McMillan were the first teenage recipients of the Australian-made vaccine which Professor Frazer and his late research partner Dr Jian Zhou helped create.

The vaccine prevents four of dozens of strains of the human papillomavirus (HPV) which cause genital warts and cervical cancer.

The prescription-only vaccine is distributed in Australia and New Zealand by Melbourne based pharmaceutical manufacturer CSL and distributed worldwide by US drugmaker Merck & Co.

It sells for $465 for a three-dose shot but there are plans to have it considered for subsidy under the Pharmaceutical Benefits Scheme and eventually added to the national vaccination program for girls aged 12.

Professor Frazer, the immunologist named 2006 Australian of the Year for his team's work on the vaccine, is the Director of UQ's Centre for Immunology and Cancer Research.

Queensland Treasurer Anna Bligh announced a new Senior Smart State Fellowship at the vaccine launch in honour of Dr Zhou.

Ms Bligh said the three-year, $450,000 Jian Zhou Fellowship would be offered to a Queenslander to advance research and development in immunology and cancer research.

The State Government will contribute $100,000 a year for three years, matched by a $50,000-a-year commitment from CSL.

Professor Zhou's son Andreas, a 20-year-old industrial design student, said he was proud of his father's legacy.

"We're really happy that the vaccine has come through with 100 percent on the test trials but also really sad because my father can't be here with us today," Mr Zhou said.

"We're happy it's finally out there and people can start getting vaccinated."

Gardasil has been approved for use in girls and women aged nine to 26 in Australia and the US.

Cervical cancer kills about 270,000 women worldwide each year.

HPV causes abnormal cells or tissue growth on the feet, hands, vocal cords, mouth and genitals.

About 60 types of HPV have been identified so far with each strand infecting certain parts of the body.

UQ's main commercialisation company, UniQuest licensed the vaccine technology to CSL in 1994.

The vaccine, predicted to become an international "blockbuster" drug, is expected to become one of the first Australian pharmaceutical successes to result in a fair share of economic flow back into the country.

 

-
 

http://www.researchaustralia.com.au

 
Subscribe to Vaccination Newsletter
E-mail Address:

 



Related Vaccination News

First ever shots of the cervical cancer vaccine administered in Queensland
Scientists one step closer to cancer vaccine
Response to Cancer Vaccine Enhanced by Chemotherapy
Ligand Treatment of Treg Cells Enhanced Anti-Tumor Immunity
Prostate Cancer Vaccine gets Special Protocol Assessment by FDA
A Vaccine For Carcinoma Cervix
Use of iNKT cells boosts tumor vaccination strategy
First integrated immune cell response promises hope in cancer vaccine research


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us